Clinical Trial: Myo-Inositol for Ovarian Stimulation and ICSI Outcomes in Women With PCOS

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779850) titled 'Myo-Inositol for Ovarian Stimulation and ICSI Outcomes in Women With PCOS' on Aug. 13.

Brief Summary: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that may affect ovarian function, insulin sensitivity, and fertility. Myo-inositol has been proposed as an insulin-sensitizing supplement that may improve metabolic and reproductive outcomes in women with PCOS.

This randomized, double-blind clinical trial evaluated the effect of myo-inositol supplementation on controlled ovarian stimulation and assisted reproductive technology (ART) outcomes in women with PCOS undergoing in vitro fertilization (IVF) and/or intracytopla...